Related Experiment Video

Updated: Jun 1, 2026

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
10:04

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Published on: October 29, 2012

Nicotine decreases food intake through activation of POMC neurons

Yann S Mineur1, Alfonso Abizaid, Yan Rao

  • 1Department of Psychiatry, Yale University School of Medicine, 34 Park Street, Third Floor Research, New Haven, CT 06508, USA.

Science (New York, N.Y.)
|June 11, 2011
PubMed

Insights

Nicotine from smoking reduces appetite by activating specific brain receptors that control food intake. This research reveals how smoking impacts weight and offers targets for obesity and smoking cessation treatments.

Area of Science:

  • Neurobiology
  • Endocrinology
  • Pharmacology

Background:

  • Smoking is linked to reduced appetite and weight control.
  • Understanding the neurobiological basis of smoking's anorexic effects is crucial for developing cessation and obesity treatments.

Purpose of the Study:

  • To elucidate the neurobiological mechanisms behind nicotine-induced appetite suppression.
  • To identify the specific neural pathways and receptors involved in nicotine's effect on food intake and body weight.

Main Methods:

  • Utilized a combination of pharmacological, molecular genetic, electrophysiological, and feeding studies in mice.
  • Investigated the role of hypothalamic nicotinic acetylcholine receptors and the melanocortin system.

Main Results:

  • Activation of hypothalamic α3β4 nicotinic acetylcholine receptors stimulates pro-opiomelanocortin (POMC) neurons.
  • POMC neurons and melanocortin 4 receptors are essential for nicotine's appetite-reducing effects in mice.
  • Nicotine was shown to decrease food intake and body weight via the hypothalamic melanocortin system.

Conclusions:

  • Nicotine decreases food intake and body weight by modulating the hypothalamic melanocortin system.
  • Identified key molecular and synaptic mechanisms underlying nicotine's appetite-suppressing effects.
  • Provides a foundation for novel therapeutic strategies for smoking cessation and obesity management.

More Related Videos

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration08:47

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration

Published on: February 10, 2012

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Brainstem: Control Centers of Medulla01:21

Brainstem: Control Centers of Medulla

The medulla oblongata is a crucial part of the brainstem responsible for controlling various autonomic and involuntary functions. It contains several nuclei, including the olivary, cuneate, gracile, and solitary nuclei.
Olivary Nucleus
The olivary nucleus, or inferior olivary nucleus, is located within the ventrolateral part of the medulla oblongata. It is primarily involved in motor coordination and motor learning. The olivary nucleus receives input from the spinal cord, cerebellum, and motor...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...